Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Litx plus chemotherapy versus chemotherapy alone for recurrent colorectal liver metastases
2006-004214-41Phase 3Completed
- Sponsor
- Light Science Oncology
- Start
- Mar 2007
- Modality
- Light/Condition-Responsive Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of talaporfin sodium in colorectal cancer (CRC) (2 arms), sponsored by Light Science Oncology. Primary endpoint: progression-free survival. Started Mar 2007; status: completed.
02
Drugs
talaporfin sodium
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on 2006-004214-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004214-41.